The Boston Keratoprosthesis: Comparing Corneal Epithelial Cell Compatibility with Titanium and PMMA

被引:33
|
作者
Ament, Jared D. [1 ,2 ]
Spurr-Michaud, Sandra J. [1 ]
Dohlman, Claes H. [1 ,2 ]
Gipson, Ilene K. [1 ]
机构
[1] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA
关键词
Boston Keratoprosthesis; biomaterials; titanium; corneal cell compatibility; INTRAOCULAR LENSES; RESIDUAL MONOMER; BIOMATERIALS; CYTOTOXICITY; PARTICLES; RESINS;
D O I
10.1097/ICO.0b013e31819670ac
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To determine in vitro whether titanium is superior corneal cell compatibility to standard polymethyl-methacryl ate (PMMA) for the Boston Keratoprosthesis (KPro). Methods: Human corneal-limbal epithelial (HCLE) cells were Cultured 24, 48, 72 96, 120, 144. or 168 hours in culture plates alone (controls) or with PMMA or titanium discs. Experiments were performed in triplicate and repeated (final n = 6). To determine if a Soluble, toxic factor is emitted from materials, concurrent experiments at 48 and 144 hours were performed with discs placed in Transwell Supports, with HCLE cells plated beneath. As an additional test for soluble factors, cells were incubated 24 hours with disc-conditioned media, and number of viable cells per well was quantified at each timepoint by proliferation assay. To determine if delayed cell proliferation was attributable to cell death, HCLE cell death was measured under all conditions and quantified at each timepoint by cytotoxicity assay. The effects of material on HCLE cell proliferation over time was determined by repeated measures ANOVA. P < 0.05 was statistically significant. Results: HCLE cell proliferation was greater in wells with titanium discs compared to PMMA. Differences between the test discs and control non-disc cocultures were statistically significant over time for both cell proliferation (P = 0.001) and death (P = 0.0025). No significant difference Was found using Transwells (P = 0.9836) or disc-conditioned media (P = 0.36). Conclusion: This in vitro HCLE cell model demonstrates significantly increased cell proliferation and decreased cell death with cell/titanium contact compared to cell/PMNA contact. Moreover, differences are unlikely attributable to a soluble factor. Prospective in vivo analysis of the two KPro biomaterials is indicated.
引用
收藏
页码:808 / 811
页数:4
相关论文
共 50 条
  • [31] Repair of an exposed glaucoma tube with a corneal graft in a patient with a Boston type 1 keratoprosthesis
    Oydanich, M.
    Khouri, A. S.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2024, 47 (02):
  • [32] Management of corneal melt in patients with Boston Keratoprosthesis Type 1: Repair versus repeat
    Daoud, Roy
    Sabeti, Saama
    Harissi-Dagher, Mona
    OCULAR SURFACE, 2020, 18 (04): : 713 - 717
  • [33] Clinical Features and Prognosis of Boston Type I Keratoprosthesis-associated Corneal Melt
    Utine, Canan Asli
    Tzu, Jonathan H.
    Akpek, Esen K.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2011, 19 (06) : 413 - 418
  • [34] Boston-keratoprosthesis for Idiopathic Limbal Stem Cell Deficiency
    Mohamed, Ashik
    Shah, Ritu
    Sangwan, Virender S.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2018, 26 (05) : 689 - 692
  • [35] Outcomes and complications of Boston keratoprosthesis type I implantation in unilateral versus bilateral corneal blindness
    Touma, Samir
    Harissi-Dagher, Mona
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2021, 56 (02): : 130 - 136
  • [36] Boston type I keratoprosthesis versus penetrating keratoplasty following a single failed corneal graft
    Jonathan El-Khoury
    Diana Khair
    Roy Daoud
    Paul Thompson
    Louis Racine
    Mona Harissi-Dagher
    Eye, 2023, 37 : 486 - 491
  • [37] Boston Keratoprosthesis Type 1 Surgery: Use of Frozen Versus Fresh Corneal Donor Carriers
    Robert, Marie-Claude
    Biernacki, Katarzyna
    Harissi-Dagher, Mona
    CORNEA, 2012, 31 (04) : 339 - 345
  • [38] Corneal Melt after Boston Keratoprosthesis: Clinical Presentation, Management, Outcomes and Risk Factor Analysis
    Bouhout, Soumaya
    Robert, Marie-Claude
    Deli, Sousans
    Harissi-Dagher, Mona
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2018, 26 (05) : 693 - 699
  • [39] Boston type I keratoprosthesis versus penetrating keratoplasty following a single failed corneal graft
    El-Khoury, Jonathan
    Khair, Diana
    Daoud, Roy
    Thompson, Paul
    Racine, Louis
    Harissi-Dagher, Mona
    EYE, 2023, 37 (03) : 486 - 491
  • [40] Surface Modification of PMMA to Improve Adhesion to Corneal Substitutes in a Synthetic Core-Skirt Keratoprosthesis
    Riau, Andri K.
    Mondal, Debasish
    Yam, Gary H. F.
    Setiawan, Melina
    Liedberg, Bo
    Venkatraman, Subbu S.
    Mehta, Jodhbir S.
    ACS APPLIED MATERIALS & INTERFACES, 2015, 7 (39) : 21690 - 21702